Battle with Olympus forces drastic cuts at Xillix
This article was originally published in Clinica
Executive Summary
Xillix Technologies is being forced to slash its workforce and cancel clinical testing to enable it to pursue theft of trade secrets claims against Olympus Optical. The much-reduced company, says Xillix, will be able to support existing customers and will aggressively search for new development partners.